Viewing StudyNCT00443872



Ignite Creation Date: 2024-05-05 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00443872
Status: COMPLETED
Last Update Posted: 2014-10-31
First Post: 2007-03-03

Brief Title: Efficacy of Orally Disintegrating Selegiline in Parkinsons Patients Experiencing Adverse Effects With Dopamine Agonists
Sponsor: Parkinsons Disease and Movement Disorder Center of Boca Raton
Organization: Parkinsons Disease and Movement Disorder Center of Boca Raton

Conditions & Keywords Data

Conditions:
Name
Parkinsons Disease
Keywords:
Name View
Zelapar View
Parkinsons disease View
Dopamine agonist adverse effects View
MAO-B inhibitor View
orally disintegrating selegiline View